Page last updated: 2024-08-23

daunorubicin and Abnormalities, Autosome

daunorubicin has been researched along with Abnormalities, Autosome in 111 studies

Research

Studies (111)

Timeframe	Studies, this research(%)	All Research%
pre-1990	53 (47.75)	18.7374
1990's	24 (21.62)	18.2507
2000's	26 (23.42)	29.6817
2010's	7 (6.31)	24.3611
2020's	1 (0.90)	2.80

Authors

Authors	Studies
Arber, DA; Erba, HP	1
Chen, J; Chen, L; Gao, L; Gong, S; Hu, X; Liu, M; Lu, S; Ni, X; Qiu, H; Song, X; Wang, J; Wang, L; Xu, S; Xu, X; Yang, J; Zhang, W	1
Beltrão, EI; Benicio, MT; Bezerra, MA; Bezerra, MF; Coelho-Silva, JL; Lucena-Araujo, AR; Machado, CG; Nascimento, JC; Rego, EM; Rocha, CR	1
Li, Y; Mi, Y; Qiu, L; Wang, J; Zhao, Y; Zou, D	1
Bian, S; Fu, M; Lin, D; Liu, J; Mi, Y; Wang, J; Wang, Y; Yu, W	1
Hu, NP; Hu, XM; Li, L; Liu, C; Liu, F; Ma, R; Wang, HZ; Xiao, HY; Xu, YG; Yang, XH; Zhang, SS; Zheng, CM	1
Attarbaschi, A; Dworzak, MN; Gadner, H; Haas, OA; Harbott, J; Inthal, A; Janousek, D; König, M; Krehan, D; Mann, G; Möricke, A; Nebral, K; Niggli, F; Panzer-Grümayer, R; Pichler, H; Schrappe, M; Strehl, S; Teigler-Schlegel, A	1
Borthakur, G; Estey, EE	1
Bocchia, M; Crupi, R; Defina, M; Gozzetti, A; Lauria, F; Pietrini, A; Raspadori, D; Rondoni, M	1
Ariffin, H; Kwok, CS; Quah, TC; Tay, SK; Yeoh, AE	1
Atkinson, HD; Colovic, M; Colovic, N; Jankovic, G; Kraguljac, N; Radojkovic, M; Stanisavljevic, D; Suvajdzic, N; Tomin, D; Vidovic, A	1
Arthur, DC; Bloomfield, CD; Byrd, JC; Carroll, AJ; Davey, FR; Dodge, RK; Edwards, CG; Feldman, EJ; Koduru, PR; Larson, RA; Mayer, RJ; Moore, JO; Mrózek, K; Patil, SR; Pettenati, MJ; Rao, KW; Schiffer, CA; Stone, RM; Watson, MS	1
Lage, H; Poland, J; Sinha, P; Tönnies, H	1
Alvarez, Y; Bastida, P; Caballín, MR; Coll, MD; Ortega, JJ	1
Okamoto, Y; Pui, CH; Razzouk, BI; Ribeiro, RC; Shenep, JL; Srivastava, DK	1
Abhyankar, D; Advani, S; Amare Kadam, P; Baisane, C; Bakshi, C; Banavali, S	1
Brien, B; Chang, H; Minden, MD; Patterson, B; Salma, F; Yi, QL	1
Graf, M; Hecht, K; Nuessler, V; Pelka-Fleischer, R; Pfister, K; Reif, S; Schmetzer, H	1
Bloomfield, CD; Carroll, AJ; Edwards, CG; Kolitz, JE; Larson, RA; Maharry, K; Marcucci, G; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Powell, BL; Ruppert, AS; Schiffer, CA; Sterling, LJ; Vardiman, JW	1
Hassan, HT; Lu, C	1
Bouabdallah, K; Daskalakis, M; Johansson, B; Kunzmann, R; Lübbert, M; Mauritzson, N; Müller-Berndorff, H; Onida, F; Schmitt-Gräff, A	1
Hirokawa, M; Horiuchi, T; Kameoka, J; Miura, I; Miyamura, K; Nomura, J; Okuda, M; Sasaki, T; Sawada, K	1
Barnett, MJ; Bruyere, H; Dalal, BI	1
Bengtzen, S; Concha, H; Lehmann, S; Merup, M; Möllgård, L; Nahi, H; Paul, C; Selivanova, G; Svensson, A; Wiman, KG	1
Arimori, S; Nagao, T	1
Biedler, JL; Chang, TD; Meyers, MB; Peterson, RH; Spengler, BA	1
Cassileth, PA	1
Gol'dberg, ED; Novitskiĭ, VV; Pichugina, TV	1
Gustavsson, A; Mitelman, F; Olofsson, T; Olsson, I	1
Dohy, H; Kamada, N; Kuramoto, A; Maehama, S; Mandai, K; Oguma, N; Tahara, E; Takimoto, Y; Tanaka, K	1
Cuttner, J; Dimitriu-Bona, A; Najfeld, V; Seremetis, S; Winchester, RA	1
Adamson, JW; Arlin, ZA; Clarkson, BD; Fialkow, PJ; Kempin, SJ; Najfeld, V; Singer, JW	1
Cooperman, BS; Klinger, HP	1
Iizawa, Y; Kamiguchi, Y; Mikamo, K; Tateno, H	1
Kamiguchi, Y; Tateno, H	1
Creutzig, U; Harbott, J; Löffler, H; Ludwig, WD; Riehm, H; Ritter, J; Schellong, G; Sperling, C; Zimmermann, M	1
Demidova, NS; Goncharova, SA; Konovalova, NP; Shiriaeva, OA	1
Ohno, R	1
Del Poeta, G; Delaroche, I; Masi, M; Nicoletti, B; Papa, G; Stasi, R; Tedeschi, B; Tribalto, M; Venditti, A; Vernole, P	1
Asou, H; Awaya, N; Ikeda, Y; Kamada, N; Kawai, Y; Kizaki, M; Matsushita, H; Muto, A; Takayama, N; Ueno, H	1
Belotti, D; Corneo, G; Maffè, PF; Pogliani, EM; Rivolta, GF	1
Ellard, S; Parry, EM; Parry, JM; Stemp, G; Toper, S; Wilcox, P	1
Appelbaum, FR; Chen, IM; Godwin, J; Head, DR; Kopecky, KJ; Leith, CP; McConnell, T; Slovak, ML; Willman, CL	1
Arthur, DC; Bigner, S; Bloomfield, CD; Carroll, AJ; Davey, FR; Lawrence, D; Mayer, RJ; Mrózek, K; Pettenati, MJ; Rao, KW; Schiffer, CA; Slack, JL; Tantravahi, R	1
de Nully Brown, P; Geisler, CH; Jurlander, J; Pedersen-Bjergaard, J; Victor, MA	1
Aricò, M; Basso, G; Biondi, A; Conter, V; De Rossi, G; Di Tullio, MT; Lo Nigro, L; Masera, G; Messina, C; Miniero, R; Mori, PG; Pession, A; Rizzari, C; Rondelli, R; Santoro, N; Silvestri, D; Tamaro, P; Testi, A; Valsecchi, MG	1
Aul, C; Büchner, T; Fonatsch, C; Gassmann, W; Haase, D; Haferlach, T; Heinecke, A; Heyll, A; Hiddemann, W; Hossfeld, D; Lengfelder, E; Löffler, H; Ludwig, WD; Maschmeyer, G; Sauerland, MC; Schoch, C; Wörmann, B	1
Mandelli, F; Montefusco, E	1
Arber, D; Dagis, A; Forman, SJ; Margolin, KA; Nademanee, A; Niland, J; O'Donnell, MR; Parker, PM; Schmidt, GM; Slovak, ML; Smith, EP; Snyder, DS; Somlo, G; Stein, AS	1
Lorsbach, RB; Mathew, S; Raimondi, SC; Sandlund, JT; Shearer, P	1
Bordessoule, D; Castaigne, S; Chevret, S; Chomienne, C; Cony Makhoul , P; De Botton , S; Deconinck, E; Degos, L; Desablens, B; Dombret, H; Fegueux, N; Fenaux, P; Fey, M; Gardin, C; Geiser, K; Guerci, A; Hess, U; Huguet, F; Link, H; Maloisel, F; Preudhomme, C; Rayon, C; San Miguel , J; Sanz, M; Solary, E; Sotto, JJ; Stamatoullas, A; Thomas, X; Travade, P	1
Büchner, T; Fonatsch, C; Haase, D; Haferlach, T; Heinecke, A; Hiddemann, W; Löffler, H; Sauerland, MC; Schlegelberger, B; Schoch, C; Staib, P	1
Eden, O; Gibson, B; Hann, I; Harrison, C; Harrison, G; Hill, F; Richards, S; Vora, A	1
Bernasconi, P; Boni, M; Castoldi, GL; Ciolli, S; Clavio, M; Cox, MC; Cuneo, A; Del Poeta, G; Dini, D; Falzetti, D; Fanin, R; Gobbi, M; Isidori, A; Leoni, F; Liso, V; Malagola, M; Mandelli, F; Martinelli, G; Mecucci, C; Petti, MC; Piccaluga, PP; Rondelli, R; Russo, D; Sessarego, M; Specchia, G; Testoni, N; Torelli, G; Tura, S; Visani, G	1
Calasanz, MJ; Gesk, S; Grote, W; Harder, L; Martín-Subero, JI; Novo, FJ; Schlegelberger, B; Schoch, R; Siebert, R	1
Burnett, AK; Chatters, S; Goldstone, AH; Grimwade, D; Harrison, CJ; Harrison, G; Oliver, F; Walker, H; Wheatley, K	1
Adachi, S; Akiyama, Y; Hamahata, K; Kubota, M; Lin, YW; Nakahata, T; Watanabe, K	1
Bendix, K; Hokland, P; Kjeldsen, E; Kristensen, JS; Meyer, K; Nørgaard, JM; Olesen, G; Olesen, LH; Pedersen, B	1
Vig, BK	4
Badia, L; Besalduch, J; Marty, ML; Mayans, J; Prieto, F	1
San, RH; Stich, HF; Stich, W	1
Gol'dberg, ED; Koĭfman, EK; Kurlov, OV	1
Brodsky, I; Conroy, JF; Fuscaldo, KE; Kahn, SB; Lamping, CG	1
Sumner, AT	1
Abella, E; Alvarado, CS; Chauvenet, A; Dubowy, R; Harris, M; Inoue, S; Krischer, JP; Ravindranath, Y; Ritchey, AK; Wiley, J	1
Belin, T; Champlin, R; Gajewski, J; Lee, M; Nimer, S; Schiller, G; Territo, M	1
Kawakubo, K; Ohto, T; Ohyashiki, JH; Ohyashiki, K; Tauchi, T; Toyama, K	1
Elliott, S; Marlton, P; Meagher, D; Rodwell, R; Taylor, D; Taylor, K; Timms, P; White, S; Wiley, J; Wright, S	1
Challinor, P; Ng, JP; Strevens, MJ	1
Jäger, U; Köller, U; Koller-Weber, E; Marosi, C; Nowotny, H; Pirc-Danoewinata, H; Schneider, B; Schwarzinger, I; Steger, G; Vahls, P	1
Andreeff, M; Haimi, J; Hegewisch, S; Jhanwar, S; Redner, A; Steinherz, P	1
Kowal-Vern, A; Melnyk, A	1
Burns, CP; Lazarus, HM; Vogler, WR; Winton, EF	1
Bradley, MO; Kao-Shan, CS; Pommier, Y; Whang-Peng, J; Zwelling, LA	1
Dmitrevskaia, TV; Kharlamova, SB	1
Abe, T; Kamakura, M; Kida, M; Kinoshita, T; Konno, S; Ryu, T; Uehara, M	1
Marquardt, H; Steinheider, G; Westendorf, J	1
Gol'dberg, ED; Klimova, MIu; Novitskiĭ, VV	1
Bligham, G; Freireich, EJ; Gehan, E; Hester, JP; Kantarjian, HM; Keating, MJ; McCredie, KB; Smith, TL; Talpaz, M; Walters, RS	1
Groth, G; Marquardt, H; Steinheider, G; Westendorf, J	1
Canellos, GP; Whang-Peng, J	1
Sinkus, AG	2
Baccarani, M; Bagnara, GP; Tura, S	1
Khan, MH	3
Cain, F; Havard, CW; Marcovitch, H	1
Sakurai, M; Sandberg, AA	1
Catovsky, D; Costello, C; Galton, DA; Goldman, JM; Spiers, AD	1
Kuliev, AM; Sinkus, AG	1
Jensen, MK	1
Cohen, M; Edwards, JA; Freeman, AI; Sinks, LF	1
Bempong, MA	1
Pogosyants, EE; Stromskaya, TP	1
Chériè Lignière, EL; Esposito, S; Marini, G; Robustelli della Cuna, G	1
Bisldi, GP; Pollini, G; Robustelli della Cuna, G	1
Ballerini, G	1
Jensen, MK; Philip, P	1
Dano, K; Hasholt, L; Visfeldt, J	1
Adamson, JW; Leventhal, BG; Perry, S; Whang-Peng, J	1
Guanti, G; Santoro, A; Schettini, F; Violante, N	1
Burgess, MA; de Gruchy, GC; Garson, OM	1
De Grouchy, J; De Nava, C	1
Massimo, L	1
Kontras, SB; Samuels, LD; Vig, BK	2
Di Marco, A	1

Reviews

8 review(s) available for daunorubicin and Abnormalities, Autosome

Article	Year
Diagnosis and Treatment of Patients With Acute Myeloid Leukemia With Myelodysplasia-Related Changes (AML-MRC). American journal of clinical pathology, 2020, 11-04, Volume: 154, Issue:6 Topics: Aged; Aminopyridines; Antineoplastic Agents; Blood Cells; Bone Marrow; Bone Marrow Examination; Chromosome Aberrations; Cytarabine; Cytogenetic Analysis; Daunorubicin; DNA Mutational Analysis; Genetic Predisposition to Disease; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Prognosis; PubMed; Triazines	2020
Therapy of acute myelogenous leukemia in adults. Cancer treatment and research, 2010, Volume: 145 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Clinical Trials as Topic; Combined Modality Therapy; Core Binding Factors; Cytarabine; Daunorubicin; Hematopoietic Stem Cell Transplantation; Humans; Leukemia, Myeloid, Acute; Middle Aged; Neoplasm Proteins; Neoplasm, Residual; Prognosis; Remission Induction; Risk; Salvage Therapy; Treatment Outcome	2010
AML1 amplification in a child with acute lymphoblastic leukemia. Cancer genetics and cytogenetics, 2003, Jan-01, Volume: 140, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chromosome Aberrations; Chromosome Painting; Chromosomes, Human, Pair 21; Core Binding Factor Alpha 2 Subunit; Cyclophosphamide; Daunorubicin; DNA-Binding Proteins; Female; Gene Amplification; Humans; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Proto-Oncogene Proteins; Remission Induction; Transcription Factors; Vincristine	2003
Viridans streptococcal sepsis: clinical features and complications in childhood acute myeloid leukemia. Journal of pediatric hematology/oncology, 2003, Volume: 25, Issue:9 Topics: Acute Disease; Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cytarabine; Daunorubicin; Deoxyadenosines; Double-Blind Method; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Hypotension; Immunocompromised Host; Leukemia, Myeloid; Male; Mycoses; Neutropenia; Randomized Controlled Trials as Topic; Respiratory Distress Syndrome; Retrospective Studies; Sepsis; Streptococcal Infections; Viridans Streptococci	2003
Drug resistance in Chinese hamster lung and mouse tumor cells. Cancer treatment reports, 1983, Volume: 67, Issue:10 Topics: Animals; Antineoplastic Agents; Cell Line; Chromosome Aberrations; Cricetinae; Cricetulus; Daunorubicin; Drug Resistance; Gangliosides; Gene Amplification; Glycoproteins; Lung; Mice; Neoplasms, Experimental; Phenotype; Phosphorylation; Proteins; Tetrahydrofolate Dehydrogenase; Vincristine	1983
Adult acute nonlymphocytic leukemia. The Medical clinics of North America, 1984, Volume: 68, Issue:3 Topics: Acute Disease; Adult; Aged; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Humans; Leukemia; Meningeal Neoplasms; Methotrexate; Middle Aged; Thioguanine	1984
[Treatment of acute and chronic leukemias]. Recenti progressi in medicina, 1999, Volume: 90, Issue:11 Topics: Acute Disease; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosome Aberrations; Combined Modality Therapy; Daunorubicin; Humans; Idarubicin; Karyotyping; Leukemia; Leukemia, Hairy Cell; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Randomized Controlled Trials as Topic; Transplantation, Autologous; Transplantation, Homologous	1999
The prognostic value of cytogenetics is reinforced by the kind of induction/consolidation therapy in influencing the outcome of acute myeloid leukemia--analysis of 848 patients. Leukemia, 2001, Volume: 15, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Combined Modality Therapy; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Hepatomegaly; Humans; Idarubicin; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Retrospective Studies; Splenomegaly; Survival Analysis; Translocation, Genetic; Treatment Outcome	2001

Trials

17 trial(s) available for daunorubicin and Abnormalities, Autosome

Article	Year
Effect and prognostic analysis of treatment for acute myeloid leukemia using Chinese drugs combined with chemotherapy. Chinese journal of integrative medicine, 2009, Volume: 15, Issue:3 Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Chromosome Aberrations; Cytarabine; Daunorubicin; Drugs, Chinese Herbal; Etoposide; Female; Humans; Immunophenotyping; Integrative Medicine; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Prognosis; Treatment Outcome; Young Adult	2009
Prognostic relevance of dic(9;20)(p11;q13) in childhood B-cell precursor acute lymphoblastic leukaemia treated with Berlin-Frankfurt-Münster (BFM) protocols containing an intensive induction and post-induction consolidation therapy. British journal of haematology, 2010, Volume: 149, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosome Aberrations; Chromosomes, Human, Pair 20; Chromosomes, Human, Pair 9; Daunorubicin; Female; Follow-Up Studies; Humans; In Situ Hybridization, Fluorescence; Infant; Karyotyping; Male; Neoplasm, Residual; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Survival Analysis; Treatment Outcome; Vincristine	2010
Mitochondrial D-loop polymorphisms and mitochondrial DNA content in childhood acute lymphoblastic leukemia. Journal of pediatric hematology/oncology, 2011, Volume: 33, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Case-Control Studies; Child; Child, Preschool; Chromosome Aberrations; Daunorubicin; Dexamethasone; DNA, Mitochondrial; Female; Fetal Blood; Humans; Male; Mitochondria; Neoplasm, Residual; Polymorphism, Genetic; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Remission Induction; Vincristine	2011
Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood, 2002, Dec-15, Volume: 100, Issue:13 Topics: Acute Disease; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Inversion; Chromosomes, Human; Cytarabine; Daunorubicin; Disease-Free Survival; Follow-Up Studies; Humans; Incidence; Karyotyping; Leukemia, Myeloid; Life Tables; Prospective Studies; Recurrence; Remission Induction; Risk Factors; Survival Analysis; Translocation, Genetic; Treatment Outcome; Trisomy	2002
Clinical significance of surface antigen expression in children with acute myeloid leukemia: results of study AML-BFM-87. Blood, 1995, Oct-15, Volume: 86, Issue:8 Topics: Acute Disease; Adolescent; Antibodies, Monoclonal; Antigens, CD; Antigens, Neoplasm; Antigens, Surface; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Humans; Immunophenotyping; Infant; Leukemia, Myeloid; Neoplastic Stem Cells; Predictive Value of Tests; Prognosis; Proportional Hazards Models; Prospective Studies; Sensitivity and Specificity; Treatment Outcome	1995
[Differentiation therapy of acute promyelocytic leukemia with all-trans retinoic acid]. Gan to kagaku ryoho. Cancer & chemotherapy, 1993, Volume: 20, Issue:2 Topics: Administration, Oral; Chromosome Aberrations; Daunorubicin; Disseminated Intravascular Coagulation; Humans; Leukemia, Promyelocytic, Acute; Prospective Studies; Remission Induction; Tretinoin	1993
Anthracycline drugs and MDR expression in human leukemia. Cytotechnology, 1996, Volume: 19, Issue:3 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Neoplasm Proteins; Neoplastic Stem Cells; Prognosis; Remission Induction; Survival Analysis; Treatment Outcome	1996
Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southwest Oncology Group study. Blood, 1997, May-01, Volume: 89, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Antigens, CD; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Double-Blind Method; Drug Resistance, Multiple; Female; Granulocyte Colony-Stimulating Factor; Humans; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Recombinant Proteins	1997
Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Haematologica, 1998, Volume: 83, Issue:9 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Disease-Free Survival; Doxorubicin; Female; Humans; Infant; Italy; Leucovorin; Male; Mercaptopurine; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Remission Induction; Risk; Thioguanine; Treatment Outcome; Vincristine	1998
Double induction strategy for acute myeloid leukemia: the effect of high-dose cytarabine with mitoxantrone instead of standard-dose cytarabine with daunorubicin and 6-thioguanine: a randomized trial by the German AML Cooperative Group. Blood, 1999, Jun-15, Volume: 93, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Humans; Karyotyping; L-Lactate Dehydrogenase; Leukemia, Myeloid, Acute; Leukocyte Count; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Thioguanine; Treatment Outcome	1999
Additional chromosomal abnormalities in patients with acute promyelocytic leukaemia (APL) do not confer poor prognosis: results of APL 93 trial. British journal of haematology, 2000, Volume: 111, Issue:3 Topics: Adult; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 12; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 16; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 6; Chromosomes, Human, Pair 7; Chromosomes, Human, Pair 8; Chromosomes, Human, Pair 9; Cohort Studies; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate; Translocation, Genetic; Tretinoin; Trisomy	2000
Patients with de novo acute myeloid leukaemia and complex karyotype aberrations show a poor prognosis despite intensive treatment: a study of 90 patients. British journal of haematology, 2001, Volume: 112, Issue:1 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Chromosome Aberrations; Cytarabine; Cytogenetic Analysis; Daunorubicin; Disease-Free Survival; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Remission Induction; Thioguanine	2001
Determinants of outcome after intensified therapy of childhood lymphoblastic leukaemia: results from Medical Research Council United Kingdom acute lymphoblastic leukaemia XI protocol. British journal of haematology, 2001, Volume: 113, Issue:1 Topics: Adolescent; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Female; Humans; Infant; Leukocyte Count; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Prognosis; Remission Induction; Risk Factors; Sex Factors; Thioguanine; United Kingdom; Vincristine	2001
The predictive value of hierarchical cytogenetic classification in older adults with acute myeloid leukemia (AML): analysis of 1065 patients entered into the United Kingdom Medical Research Council AML11 trial. Blood, 2001, Sep-01, Volume: 98, Issue:5 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Interferon-alpha; Karyotyping; Lenograstim; Leukemia, Myeloid; Life Tables; Male; Middle Aged; Predictive Value of Tests; Prednisone; Prognosis; Recombinant Proteins; Remission Induction; Survival Analysis; Thioguanine; Treatment Outcome; United Kingdom; Vincristine	2001
Chronic myelogenous leukemia: a clinical and experimental evaluation of splenectomy and intensive chemotherapy. Series haematologica (1968), 1975, Volume: 8, Issue:4 Topics: Adult; Antineoplastic Agents; Busulfan; Chromosome Aberrations; Chromosomes, Human, 21-22 and Y; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Evaluation; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Humans; Hydroxyurea; Leukemia, Myeloid; Male; Middle Aged; Splenectomy; Thioguanine	1975
Long-term outcome of high-dose cytarabine-based consolidation chemotherapy for adults with acute myelogenous leukemia. Blood, 1992, Dec-15, Volume: 80, Issue:12 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Drug Administration Schedule; Etoposide; Female; Follow-Up Studies; Humans; Karyotyping; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitoxantrone; Survival Analysis; Time Factors	1992
[Toxic side effects of daunomycin in children]. Blut, 1970, Volume: 20, Issue:1 Topics: Alopecia; Antibody Formation; Bone Marrow; Bone Marrow Cells; Child; Child, Preschool; Chromosome Aberrations; Daunorubicin; Drug Hypersensitivity; Heart; Humans; Immunosuppressive Agents; Inflammation; Intestinal Mucosa; Leukemia; Leukocytes; Leukopenia; Lymphocyte Activation; Mercaptopurine	1970

Other Studies

86 other study(ies) available for daunorubicin and Abnormalities, Autosome

Article	Year
High prognostic value of minimal residual disease detected by flow-cytometry-enhanced fluorescence in situ hybridization in core-binding factor acute myeloid leukemia (CBF-AML). Annals of hematology, 2014, Volume: 93, Issue:10 Topics: Adolescent; ADP-ribosyl Cyclase 1; Adult; Antigens, CD34; Antineoplastic Combined Chemotherapy Protocols; Cell Separation; Chromosome Aberrations; Consolidation Chemotherapy; Core Binding Factor Alpha 2 Subunit; Cytarabine; Daunorubicin; Female; Flow Cytometry; Humans; In Situ Hybridization, Fluorescence; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Neoplasm, Residual; Neoplastic Stem Cells; Oncogene Proteins, Fusion; Prognosis; RUNX1 Translocation Partner 1 Protein; Young Adult	2014
Association between the TP53 Arg72Pro polymorphism and clinical outcomes in acute myeloid leukemia. Haematologica, 2017, Volume: 102, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alleles; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Etoposide; Female; Gene Expression; Genetic Predisposition to Disease; Humans; Idarubicin; Leukemia, Myeloid, Acute; Male; Middle Aged; Polymorphism, Single Nucleotide; Prognosis; Retrospective Studies; Survival Analysis; Thioguanine; Tumor Suppressor Protein p53	2017
Additional chromosomal abnormalities and their prognostic significance in adult Philadelphia-positive acute lymphoblastic leukemia: with or without imatinib in chemotherapy. Annals of hematology, 2009, Volume: 88, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Benzamides; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Disease-Free Survival; Etoposide; Female; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Kaplan-Meier Estimate; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Piperazines; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prognosis; Pyrimidines; Salvage Therapy; Vincristine; Vindesine; Young Adult	2009
Intensive induction chemotherapy with regimen containing intermediate dose cytarabine in the treatment of de novo acute myeloid leukemia. American journal of hematology, 2009, Volume: 84, Issue:7 Topics: Adolescent; Adult; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Female; Harringtonines; Humans; Kaplan-Meier Estimate; Leukemia, Myeloid, Acute; Male; Middle Aged; Prognosis; Remission Induction; Young Adult	2009
A der(1)t(1;21)(p36.3;q22) in a patient with acute myelogenous leukemia M2. Acta haematologica, 2010, Volume: 124, Issue:1 Topics: Chromosome Aberrations; Cytarabine; Daunorubicin; Female; Humans; In Situ Hybridization, Fluorescence; Leukemia, Myeloid, Acute; Middle Aged; Translocation, Genetic	2010
Induction chemotherapy versus palliative treatment for acute myeloid leukemia in a consecutive cohort of elderly patients. Annals of hematology, 2012, Volume: 91, Issue:9 Topics: Acute Disease; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Blood Component Transfusion; Chromosome Aberrations; Cohort Studies; Comorbidity; Cytarabine; Daunorubicin; Etoposide; Female; Follow-Up Studies; Humans; Hydroxyurea; Immunophenotyping; Kaplan-Meier Estimate; Karyotyping; Leukemia, Myeloid; Male; Palliative Care; Remission Induction; Retrospective Studies; Serbia; Treatment Outcome	2012
Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells. International journal of cancer, 2003, Mar-01, Volume: 103, Issue:6 Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassette Transporters; Chromosome Aberrations; Daunorubicin; DNA Probes; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Amplification; Gene Deletion; Gene Expression Regulation; Genes, MDR; Hot Temperature; Humans; Mitoxantrone; Molecular Chaperones; Nucleic Acid Hybridization; Stomach Neoplasms; Tumor Cells, Cultured	2003
Chromosomal rearrangement in Down syndrome with acute myeloid leukemia. Indian journal of pediatrics, 2003, Volume: 70, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Cytarabine; Daunorubicin; Down Syndrome; Female; Humans; Leukemia, Monocytic, Acute; Thioguanine; Translocation, Genetic	2003
Prognostic relevance of immunophenotyping in 379 patients with acute myeloid leukemia. Leukemia research, 2004, Volume: 28, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Cytogenetics; Daunorubicin; DNA Nucleotidylexotransferase; Female; Humans; Immunophenotyping; Leukemia, Myeloid; Male; Middle Aged; Prognosis; Remission Induction; Survival Rate	2004
Low L-selectin (CD62L) expression in acute myeloid leukemia correlates with a bad cytogenetic risk. European journal of haematology, 2003, Volume: 71, Issue:5 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Chromosome Aberrations; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; L-Selectin; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Neoplasm Proteins; Neoplastic Stem Cells; Remission Induction; Risk; Thioguanine; Treatment Outcome; Tretinoin	2003
Prognostic factors and outcome of core binding factor acute myeloid leukemia patients with t(8;21) differ from those of patients with inv(16): a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Aug-20, Volume: 23, Issue:24 Topics: Acute Disease; Aged; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Proportional Hazards Models; Prospective Studies; Remission Induction; Statistics, Nonparametric; Survival Analysis	2005
Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells. Leukemia research, 2006, Volume: 30, Issue:3 Topics: Aged; Aged, 80 and over; Antibodies, Monoclonal; Antigens, CD34; Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; bcl-2-Associated X Protein; Biomarkers, Tumor; Blast Crisis; Cell Line, Tumor; Chromosome Aberrations; Clinical Trials as Topic; Cytarabine; Daunorubicin; Drug Evaluation, Preclinical; Drug Resistance, Neoplasm; Drug Synergism; Female; Humans; Leukemia, Myeloid, Acute; Male; Pilot Projects; Receptors, Cytokine; Stem Cell Factor; Treatment Outcome	2006
Trisomy 19 as the sole chromosomal abnormality in proliferative chronic myelomonocytic leukemia. Leukemia research, 2006, Volume: 30, Issue:8 Topics: Aged; Azacitidine; Chromosome Aberrations; Chromosomes, Human, Pair 19; Cytarabine; Cytogenetic Analysis; Daunorubicin; Decitabine; Dose-Response Relationship, Drug; Fatal Outcome; Female; Humans; Hydroxyurea; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Phenotype; Steroids; Treatment Outcome	2006
[Acute monoblastic leukemia with tetrasomy 8]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 2006, Volume: 47, Issue:8 Topics: Adult; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 8; Combined Modality Therapy; Cytarabine; Daunorubicin; Fatal Outcome; Female; Humans; Karyotyping; Leukemia, Monocytic, Acute; Peripheral Blood Stem Cell Transplantation	2006
Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia. British journal of haematology, 2007, Volume: 137, Issue:5 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Bone Marrow Examination; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Cytarabine; Daunorubicin; Humans; In Situ Hybridization, Fluorescence; Leukemia, Promyelocytic, Acute; Male; Oncogene Proteins, Fusion; Remission Induction; Translocation, Genetic; Tretinoin	2007
Mutated and non-mutated TP53 as targets in the treatment of leukaemia. British journal of haematology, 2008, Volume: 141, Issue:4 Topics: Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Death; Chromosome Aberrations; Cytarabine; Daunorubicin; Dose-Response Relationship, Drug; Drug Synergism; Furans; Genes, p53; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid, Acute; Membrane Proteins; Mutation; Nerve Tissue Proteins; Tumor Cells, Cultured; Tumor Suppressor Protein p53; Vidarabine	2008
Prognostic factors in adult patients with acute leukemia. The Tokai journal of experimental and clinical medicine, 1983, Volume: 8, Issue:5-6 Topics: Acute Disease; Adolescent; Adult; Aged; Chromosome Aberrations; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia; Leukemia, Lymphoid; Leukemia, Myeloid, Acute; Leukocyte Count; Male; Middle Aged; Prednisolone; Prognosis; Vincristine; Zinostatin	1983
[Mechanisms of hemopoiesis inhibition and recovery after the administration of carminomycin and rubomycin in an experiment]. Antibiotiki, 1984, Volume: 29, Issue:6 Topics: Animals; Bone Marrow; Bone Marrow Cells; Carubicin; Chromosome Aberrations; Daunorubicin; Depression, Chemical; Female; Hematopoiesis; Mice; Mice, Inbred BALB C; Mitosis; Rats; Time Factors	1984
The relationship between growth in agar, karyotype and prognosis in acute leukaemia. Scandinavian journal of haematology, 1984, Volume: 32, Issue:4 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Cells; Cells, Cultured; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Female; Humans; Karyotyping; Leukemia; Leukemia, Lymphoid; Male; Middle Aged; Neoplastic Stem Cells; Prednisolone; Prednisone; Prognosis; Thioguanine; Vincristine	1984
[Double minute chromosomes (DMs) in a case of acute myelocytic leukemia (M2: FAB classification)]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1984, Volume: 25, Issue:6 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid, Acute; Mercaptopurine; Prednisolone; Vincristine	1984
TdT-positive acute leukemia with monocytoid characteristics: clinical, cytochemical, cytogenetic, and immunologic findings. Blood, 1984, Volume: 64, Issue:1 Topics: Acute Disease; Adult; Aged; Antibodies, Monoclonal; Cell Membrane; Chromosome Aberrations; Cytarabine; Daunorubicin; DNA Nucleotidylexotransferase; DNA Nucleotidyltransferases; Female; Histocytochemistry; Humans; Leukemia; Male; Middle Aged; Monocytes; Neoplastic Stem Cells; Phenotype; Prednisone; Vincristine	1984
Restoration of nonclonal hematopoiesis in chronic myelogenous leukemia (CML) following a chemotherapy-induced loss of the Ph1 chromosome. Blood, 1980, Volume: 56, Issue:3 Topics: Adult; Chromosome Aberrations; Chromosomes, Human, 21-22 and Y; Clone Cells; Cytarabine; Daunorubicin; Female; Glucosephosphate Dehydrogenase; Heterozygote; Humans; Karyotyping; Leukemia, Myeloid; Thioguanine	1980
Double minute chromosomes in a case of acute myelogenous leukemia resistant to chemotherapy. Cytogenetics and cell genetics, 1981, Volume: 30, Issue:1 Topics: Aged; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Female; Humans; Karyotyping; Leukemia, Myeloid, Acute	1981
Chromosome analysis of human spermatozoa exposed to antineoplastic agents in vitro. Mutation research, 1995, Volume: 326, Issue:2 Topics: Animals; Antineoplastic Agents; Bleomycin; Cattle; Chromosome Aberrations; Cricetinae; Cyclophosphamide; Daunorubicin; Female; Fertilization in Vitro; Humans; Male; Methyl Methanesulfonate; Mitomycin; Mutagens; Oocytes; Spermatozoa; Triethylenemelamine	1995
Application of cryopreserved golden hamster oocytes to in vitro genotoxicity assays for human sperm chromosomes. Environmental and molecular mutagenesis, 1995, Volume: 25, Issue:3 Topics: Animals; Bleomycin; Cell Survival; Chi-Square Distribution; Chromosome Aberrations; Cricetinae; Cryopreservation; Daunorubicin; DNA Repair; Female; Gamma Rays; Gene Expression Regulation; Humans; Male; Mesocricetus; Mutagenicity Tests; Mutation; Oocytes; Spermatozoa	1995
[Change in the chemotherapeutic sensitivity and cytogenetic characteristics during lengthy passage of tumors with the multidrug resistance phenotype and genotype]. Doklady Akademii nauk, 1994, Volume: 339, Issue:6 Topics: Animals; Antineoplastic Agents; Chromosome Aberrations; Chromosome Disorders; Daunorubicin; Drug Resistance, Multiple; Genotype; Karyotyping; Leukemia P388; Phenotype; Vincristine	1994
Incidence of chromosome abnormalities and clinical significance of karyotype in de novo acute myeloid leukemia. Cancer genetics and cytogenetics, 1993, Volume: 67, Issue:1 Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Female; Humans; Incidence; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Prognosis; Translocation, Genetic	1993
Establishment and characterization of a novel acute promyelocytic leukemia cell line (UF-1) with retinoic acid-resistant features. Blood, 1996, Sep-01, Volume: 88, Issue:5 Topics: Adult; Antineoplastic Agents; Cell Differentiation; Cell Division; Chromosome Aberrations; Cytarabine; Daunorubicin; DNA Mutational Analysis; Drug Resistance, Neoplasm; Fatal Outcome; Female; HL-60 Cells; Humans; Immunophenotyping; Karyotyping; Leukemia, Promyelocytic, Acute; Mercaptopurine; Neoplasm Proteins; Oncogene Proteins, Fusion; Polymerase Chain Reaction; Prednisolone; Tretinoin; Tumor Cells, Cultured	1996
A comparison of conventional metaphase analysis of Giemsa-stained chromosomes with multi-colour fluorescence in situ hybridization analysis to detect chromosome aberrations induced by daunomycin. Mutagenesis, 1996, Volume: 11, Issue:6 Topics: Adult; Antibiotics, Antineoplastic; Azure Stains; Chromosome Aberrations; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 3; Chromosomes, Human, Pair 4; Chromosomes, Human, Pair 8; Daunorubicin; Humans; In Situ Hybridization, Fluorescence; Male; Metaphase; Sensitivity and Specificity	1996
Secondary cytogenetic changes in acute promyelocytic leukemia--prognostic importance in patients treated with chemotherapy alone and association with the intron 3 breakpoint of the PML gene: a Cancer and Leukemia Group B study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:5 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prognosis; Prospective Studies; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Translocation, Genetic	1997
The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia. Leukemia research, 1997, Volume: 21, Issue:10 Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Antimetabolites, Antineoplastic; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Disease-Free Survival; Female; Humans; Immunophenotyping; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Multivariate Analysis; Prognosis; Remission Induction; Retrospective Studies; Sialic Acid Binding Ig-like Lectin 3	1997
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remission. Leukemia, 2000, Volume: 14, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cerebellar Diseases; Chromosome Aberrations; Chromosome Deletion; Chromosome Inversion; Chromosomes, Human; Chromosomes, Human, Pair 7; Cytarabine; Daunorubicin; Female; Humans; Leukemia, Myeloid; Logistic Models; Male; Middle Aged; Prognosis; Remission Induction; Retrospective Studies; Sepsis; Translocation, Genetic; Treatment Outcome	2000
Double minute chromosomes and c-MYC amplification in a child with secondary myelodysplastic syndrome after treatment for acute lymphoblastic leukemia. Leukemia, 2000, Volume: 14, Issue:7 Topics: Anemia, Refractory, with Excess of Blasts; Aneuploidy; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chromosome Aberrations; Chromosomes, Human, Pair 8; Cladribine; Combined Modality Therapy; Cranial Irradiation; Cytarabine; Daunorubicin; Fatal Outcome; Female; Gene Amplification; Genes, myc; Humans; Hydrocortisone; Karyotyping; Mercaptopurine; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Vincristine	2000
Amplification of ERBB2, RARA, and TOP2A genes in a myelodysplastic syndrome transforming to acute myeloid leukemia. Cancer genetics and cytogenetics, 2001, Volume: 127, Issue:2 Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Cell Transformation, Neoplastic; Chromosome Aberrations; Chromosome Mapping; Chromosomes, Human, Pair 17; Chromosomes, Human, Pair 9; Cytarabine; Daunorubicin; DNA Topoisomerases, Type II; DNA-Binding Proteins; Female; Genes, erbB-2; Humans; In Situ Hybridization, Fluorescence; Isoenzymes; Karyotyping; Leukemia, Myelomonocytic, Acute; Metaphase; Middle Aged; Myelodysplastic Syndromes; Poly-ADP-Ribose Binding Proteins; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Thioguanine	2001
Repetitious appearance and disappearance of different kinds of clonal cytogenetic abnormalities after allogeneic bone marrow transplantation. International journal of hematology, 2001, Volume: 74, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Bone Marrow Transplantation; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Clone Cells; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Daunorubicin; DNA Damage; Female; Follow-Up Studies; Humans; In Situ Hybridization, Fluorescence; Karyotyping; Mercaptopurine; Methotrexate; Methylprednisolone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisolone; Remission Induction; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vincristine	2001
FAB M4 and high CD14 surface expression is associated with high cellular resistance to Ara-C and daunorubicin: implications for clinical outcome in acute myeloid leukaemia. European journal of haematology, 2001, Volume: 67, Issue:4 Topics: Aclarubicin; Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Amsacrine; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cohort Studies; Cytarabine; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Idarubicin; Leukemia, Myeloid; Leukemia, Myelomonocytic, Acute; Lipopolysaccharide Receptors; Male; Middle Aged; Mitoxantrone; Multivariate Analysis; Neoplastic Stem Cells; Thioguanine; Treatment Outcome	2001
Genetic toxicology of mitomycin C, actinomycins, daunomycin and adriamycin. Mutation research, 1977, Volume: 39, Issue:2 Topics: Bacteria; Biotransformation; Chromosome Aberrations; Crossing Over, Genetic; Dactinomycin; Daunorubicin; DNA; Doxorubicin; Drug Therapy, Combination; Mitomycins; Mutagens; Mutation; Recombination, Genetic	1977
[Trysomy of chromosome 1 long arms plus chromosome 9 inversion in leukaemic cells (author's transl)]. Sangre, 1978, Volume: 23, Issue:1 Topics: Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Drug Resistance; Female; Humans; Karyotyping; Leukemia, Myeloid, Acute; Middle Aged; Trisomy	1978
Differential sensitivity of Xeroderma pigmentosum cells of different repair capacities towards the chromosome breaking action of carcinogens and mutagens. International journal of cancer, 1977, Aug-15, Volume: 20, Issue:2 Topics: 4-Nitroquinoline-1-oxide; Acetoxyacetylaminofluorene; Carcinogens; Cells, Cultured; Chromosome Aberrations; Chromosomes; Daunorubicin; DNA Repair; Fibroblasts; Humans; Methylnitronitrosoguanidine; Mutagens; Xeroderma Pigmentosum	1977
[Comparative cytogenetic action of the antitumor antibiotics, carminomycin and rubomycin]. Antibiotiki, 1978, Volume: 23, Issue:6 Topics: Animals; Antibiotics, Antineoplastic; Bone Marrow; Carubicin; Chromosome Aberrations; Daunorubicin; Female; Male; Metaphase; Mutagens; Rats; Time Factors	1978
Inhibitors of topoisomerases do not block the passage of human lymphocyte chromosomes through mitosis. Journal of cell science, 1992, Volume: 103 ( Pt 1) Topics: Amsacrine; Camptothecin; Chromosome Aberrations; Chromosomes, Human; Daunorubicin; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Ellipticines; Ethidium; Etoposide; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mitoxantrone; Nalidixic Acid; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors	1992
Acute myeloid leukemia (AML) in Down's syndrome is highly responsive to chemotherapy: experience on Pediatric Oncology Group AML Study 8498. Blood, 1992, Nov-01, Volume: 80, Issue:9 Topics: Acute Disease; Adolescent; Adult; Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Azacitidine; Child; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Down Syndrome; Etoposide; Female; Follow-Up Studies; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Methotrexate; Prednisone; Remission Induction; Thioguanine; Vincristine	1992
Restoration of cytogenetically normal marrow cells after remission of lymphoblastic crisis in a case of Ph positive CML treated with alpha-interferon. Cancer genetics and cytogenetics, 1992, Volume: 58, Issue:2 Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Blast Crisis; Bone Marrow; Chromosome Aberrations; Chromosome Banding; Daunorubicin; Gene Rearrangement; Humans; Interferon-alpha; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Prednisolone; Remission Induction; Vincristine	1992
Proof of differentiative mode of action of all-trans retinoic acid in acute promyelocytic leukemia using X-linked clonal analysis. Blood, 1992, Apr-15, Volume: 79, Issue:8 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Blotting, Southern; Bone Marrow; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 15; Chromosomes, Human, Pair 17; Clone Cells; Cytarabine; Daunorubicin; DNA, Neoplasm; Etoposide; Female; Genetic Linkage; Humans; Leukemia, Promyelocytic, Acute; Translocation, Genetic; Tretinoin; X Chromosome	1992
Acute myelomonocytic leukaemia and 48,XXY, +8 chromosome anomalies. Clinical and laboratory haematology, 1992, Volume: 14, Issue:1 Topics: Antigens, CD; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Chromosome Aberrations; Chromosomes, Human, Pair 8; Cytarabine; Daunorubicin; Genes, ras; Humans; Leukemia, Myelomonocytic, Acute; Male; Middle Aged; Thioguanine; Trisomy; X Chromosome	1992
Prognostic impact of karyotype and immunologic phenotype in 125 adult patients with de novo AML. Cancer genetics and cytogenetics, 1992, Jul-01, Volume: 61, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Female; Humans; Immunophenotyping; Leukemia, Myeloid; Male; Middle Aged; Prognosis; Remission Induction; Survival Analysis	1992
A study of multidrug resistance and cell kinetics in a child with near-haploid acute lymphoblastic leukemia. Leukemia research, 1990, Volume: 14, Issue:9 Topics: Cell Cycle; Chromosome Aberrations; Daunorubicin; Drug Resistance; Haplotypes; Humans; Membrane Glycoproteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Verapamil	1990
T-cell acute lymphoblastic leukemia with t(1;18)(p36;q22). Cancer genetics and cytogenetics, 1990, Nov-01, Volume: 50, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Asparaginase; Child; Chromosome Aberrations; Chromosomes, Human, Pair 1; Chromosomes, Human, Pair 18; Cyclophosphamide; Cytarabine; Daunorubicin; Doxorubicin; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; Thioguanine; Vincristine	1990
High-dose cytosine arabinoside and daunorubicin as primary therapy in elderly patients with acute myelogenous leukemia. A phase I-II study of the Southeastern Cancer Study Group. Cancer, 1989, Mar-15, Volume: 63, Issue:6 Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Chemical and Drug Induced Liver Injury; Chromosome Aberrations; Chromosome Disorders; Cytarabine; Daunorubicin; Drug Administration Schedule; Drug Evaluation; Female; Humans; Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Remission Induction	1989
Correlations between intercalator-induced DNA strand breaks and sister chromatid exchanges, mutations, and cytotoxicity in Chinese hamster cells. Cancer research, 1985, Volume: 45, Issue:7 Topics: Aminoacridines; Amsacrine; Animals; Cell Survival; Cells, Cultured; Chromosome Aberrations; Cricetinae; Cricetulus; Daunorubicin; DNA; DNA Topoisomerases, Type I; DNA, Single-Stranded; Intercalating Agents; Mutation; Sister Chromatid Exchange	1985
[Accumulation in the regenerating liver of hepatocytes with pathological nuclei as affected by daunorubicin]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1988, Volume: 33, Issue:7 Topics: Animals; Cell Count; Cell Nucleus; Chromosome Aberrations; Daunorubicin; Dose-Response Relationship, Drug; Hepatectomy; Liver; Liver Regeneration; Male; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Mitosis; Time Factors	1988
[Chromosomal abnormalities before and after chemotherapy in a case with erythroleukemia]. [Rinsho ketsueki] The Japanese journal of clinical hematology, 1986, Volume: 27, Issue:10 Topics: Antineoplastic Combined Chemotherapy Protocols; Chromosome Aberrations; Cytarabine; Daunorubicin; Humans; Karyotyping; Leukemia, Erythroblastic, Acute; Male; Mercaptopurine; Middle Aged; Prednisolone	1986
Induction of chromosomal aberrations by the anthracycline antitumor antibiotics N,N-dimethyldaunomycin and aclacinomycin A. Experientia, 1987, May-15, Volume: 43, Issue:5 Topics: Aclarubicin; Animals; Antibiotics, Antineoplastic; Cell Line; Chromosome Aberrations; Daunorubicin; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Mutation; Naphthacenes	1987
[Comparative evaluation of the cytogenetic action of anthracycline-group antitumor antibiotics (daunomycin, doxorubicin and carminomycin)]. Antibiotiki i meditsinskaia biotekhnologiia = Antibiotics and medical biotechnology, 1986, Volume: 31, Issue:10 Topics: Animals; Bone Marrow; Carubicin; Cell Nucleus; Chromosome Aberrations; Daunorubicin; Doxorubicin; Erythrocyte Count; Metaphase; Mice; Mutation; Time Factors	1986
Chronic myelogenous leukemia: a multivariate analysis of the associations of patient characteristics and therapy with survival. Blood, 1985, Volume: 66, Issue:6 Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Basophils; Blood Cell Count; Body Weight; Bone Marrow Cells; Busulfan; Chromosome Aberrations; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Combinations; Female; Hemoglobins; Humans; Hydroxyurea; Leukemia, Myeloid; Male; Middle Aged; Philadelphia Chromosome; Prednisone; Prognosis; Risk; Vincristine	1985
Formation of DNA-adducts and induction of DNA-crosslinks and chromosomal aberrations by the new potent anthracycline antitumor antibiotics: morpholinodaunomycin, cyanomorpholinodaunomycin and cyanomorpholinoadriamycin. Cell biology and toxicology, 1985, Volume: 1, Issue:2 Topics: Animals; Antibiotics, Antineoplastic; Cells, Cultured; Chemical Phenomena; Chemistry; Chromosome Aberrations; Daunorubicin; DNA; DNA Repair; Doxorubicin; Leukemia L1210; Liver; Rats	1985
Philadelphia-chromosome-positive preleukaemic state. Lancet (London, England), 1972, Dec-09, Volume: 2, Issue:7789 Topics: Adult; Blood Cell Count; Bone Marrow Cells; Bone Marrow Examination; Chromosome Aberrations; Cytarabine; Cytogenetics; Daunorubicin; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Male; Prednisone; Thioguanine; Vincristine	1972
Alterations in the pattern of daunomycin-induced chromosomal aberrations by inhibitors of protein and DNA synthesis. Mutation research, 1970, Volume: 9, Issue:6 Topics: Chromatids; Chromosome Aberrations; Chromosomes; Crossing Over, Genetic; Culture Media; Daunorubicin; DNA; Floxuridine; Humans; In Vitro Techniques; Leukocytes; Mutagens; Protein Biosynthesis; Puromycin	1970
Cytogenetic action of rubomycin C in human lymphocyte cultures. Chromosomal aberrations at the G2 stage of the mitotic cycle. Soviet genetics, 1974, Jul-01, Volume: 8, Issue:6 Topics: Cells, Cultured; Chromatids; Chromosome Aberrations; Chromosomes; Daunorubicin; Humans; In Vitro Techniques; Lymphocytes; Mitosis; Mutagens	1974
[Therapy of the blastic crisis]. Minerva medica, 1972, Mar-31, Volume: 63, Issue:24 Topics: Adolescent; Adult; Aged; Busulfan; Chromosome Aberrations; Daunorubicin; Female; Fever; Humans; Leukemia, Myeloid; Male; Mercaptopurine; Middle Aged; Prednisone; Splenomegaly; Time Factors	1972
Acute myeloid leukemia with two Philadelphia chromosomes in forty-six stemline. Remarks on the karyotypic analysis and chemotherapy. Humangenetik, 1973, Mar-23, Volume: 18, Issue:1 Topics: Chromosome Aberrations; Chromosomes, Human, 21-22 and Y; Clone Cells; Cytogenetics; Daunorubicin; Diploidy; Humans; Karyotyping; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitosis; Prednisone; Time Factors; Vincristine	1973
Eosinophilic leukaemia. The British journal of clinical practice, 1973, Volume: 27, Issue:5 Topics: Aged; Chromosome Aberrations; Daunorubicin; Diagnosis, Differential; Eosinophils; Female; Humans; Leukemia; Leukemia, Myeloid	1973
Chromosomes and causation of human cancer and leukemia. IX. Prognostic and therapeutic value of chromosomal findings in acute myeloblastic leukemia. Cancer, 1974, Volume: 33, Issue:6 Topics: Adult; Age Factors; Aged; Antineoplastic Agents; Bone Marrow Cells; Carmustine; Chromosome Aberrations; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Erythroblastic, Acute; Leukemia, Myeloid, Acute; Male; Middle Aged; Mitosis; Nitrosourea Compounds; Prednisone; Prognosis; Thioguanine; Time Factors; Vincristine	1974
Chronic granulocytic leukaemia: multiple-drug chemotherapy for acute transformation. British medical journal, 1974, Jul-13, Volume: 3, Issue:5923 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Asparaginase; Chromosome Aberrations; Chromosomes, Human, 21-22 and Y; Cyclophosphamide; Cytarabine; Daunorubicin; Drug Therapy, Combination; Female; Humans; Leukemia, Myeloid; Male; Methotrexate; Middle Aged; Prednisolone; Thioguanine; Vincristine	1974
The evolution of the Ph1-trisomic clone, in a case of chronic myeloid leukemia. Humangenetik, 1974, Volume: 24, Issue:3 Topics: Adult; Bone Marrow; Bone Marrow Cells; Cell Count; Chromosome Aberrations; Chromosomes, Human, 21-22 and Y; Clone Cells; Cyclophosphamide; Daunorubicin; Humans; Karyotyping; Leukemia, Myeloid; Male; Recurrence; Trisomy; Vincristine	1974
[Chromosomal damage in human lymphocyte cultures following treatment with rubomycin C]. Tsitologiia, 1972, Volume: 14, Issue:9 Topics: Adolescent; Adult; Cells, Cultured; Chromosome Aberrations; Daunorubicin; Female; Humans; Leukemia; Lymphatic Diseases; Lymphocytes; Lymphoma, Large B-Cell, Diffuse; Male	1972
Heteromorphic pair of metacentric chromosomes with fused arms and the Philadelphia chromosome in a case of acute myeloid leukemia. Acta haematologica, 1972, Volume: 48, Issue:5 Topics: Blood Transfusion; Bone Marrow Cells; Cells, Cultured; Chromosome Aberrations; Chromosomes, Human, 19-20; Chromosomes, Human, 21-22 and Y; Daunorubicin; Female; Humans; Karyotyping; Lectins; Leukemia, Myeloid, Acute; Middle Aged; Prednisone; Vincristine	1972
[Chromosomal damage in a series of cell generations following application of rubomycin C to cultured human cells]. Biulleten' eksperimental'noi biologii i meditsiny, 1972, Volume: 73, Issue:11 Topics: Cells, Cultured; Chromosome Aberrations; Chromosomes; Daunorubicin; Embryo, Mammalian; Fibroblasts; Humans	1972
Phenylbutazone, chloramphenicol and mammalian chromosomes. Humangenetik, 1972, Volume: 17, Issue:1 Topics: Animals; Bone Marrow; Bone Marrow Cells; Cells, Cultured; Chloramphenicol; Chromatids; Chromosome Aberrations; Chromosomes; Daunorubicin; Humans; Lymphocytes; Male; Phenylbutazone; Rats	1972
Morphologic studies in a recently described dyserythropoietic state. Blood, 1972, Volume: 40, Issue:4 Topics: Bone Marrow Cells; Cell Nucleus; Cell Survival; Child; Chromatids; Chromium Isotopes; Chromosome Aberrations; Chromosomes, Human, 1-3; Cyclophosphamide; Cytoplasm; Daunorubicin; Electrophoresis, Starch Gel; Erythrocytes, Abnormal; Erythropoiesis; Fetal Hemoglobin; Hematopoietic Stem Cells; Hemolysis; Humans; Iron; Karyotyping; Lymphoma, Non-Hodgkin; Male; Megakaryocytes; Microscopy, Electron; Osmotic Fragility; Phagocytosis; Vincristine	1972
Interaction of daunomycin with meiotic chromosomes in Vicia faba. Canadian journal of genetics and cytology. Journal canadien de genetique et de cytologie, 1973, Volume: 15, Issue:3 Topics: Chromosome Aberrations; Chromosomes; Daunorubicin; DNA; Meiosis; Plant Cells; Plants; RNA	1973
Effect of rubomycin C and urethane on chromosomes of normal and leukemic mouse cells. Soviet genetics, 1974, Feb-01, Volume: 7, Issue:11 Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Chromosomes; Daunorubicin; Female; Leukemia, Experimental; Leukocytes; Male; Mice; Mutagens; Mutation; Neoplasm Transplantation; Spleen; Urethane	1974
[Effect of daunomycin on the number and morphology of the chromosomes. Protestive action of exogenous ribonucleic acids]. Haematologica, 1967, Volume: 52, Issue:6 Topics: Animals; Chromosome Aberrations; Chromosomes; Daunorubicin; Karyotyping; Rats; RNA	1967
[Chromosome damage by daunomycin. In vivo evaluation of the damaging dose-effect ratio]. Haematologica, 1969, Volume: 54, Issue:7 Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Chromosomes; Daunorubicin; DNA; Mitosis; Rats	1969
[Karyotype changes through antimitotic therapy. Experimental studies]. Haematologica, 1970, Volume: 55, Issue:3 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Antiviral Agents; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Daunorubicin; DNA	1970
The cytogenetic effect of rubidomycin in vivo in rats. Mutation research, 1971, Volume: 12, Issue:1 Topics: Animals; Bone Marrow; Bone Marrow Cells; Chromatids; Chromosome Aberrations; Daunorubicin; Female; Lymphocytes; Male; Rats	1971
Nature of chromosome aberrations induced in pre-Dna-synthesis period in human leukocytes by daunomycin. Mutation research, 1971, Volume: 12, Issue:4 Topics: Cells, Cultured; Chromatids; Chromosome Aberrations; Chromosomes; Culture Techniques; Daunorubicin; DNA; DNA Repair; DNA Replication; Humans; Karyotyping; Leukocytes; Mitosis; Time Factors	1971
Chromosome aberrations induced in human leukocytes by the antileukemic antibiotic adriamycin. Cancer research, 1971, Volume: 31, Issue:1 Topics: Amino Sugars; Anthraquinones; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Chromosome Aberrations; Chromosomes, Human, 1-3; Chromosomes, Human, 21-22 and Y; Culture Media; Daunorubicin; Humans	1971
Karyotypic profile alterations in Ehrlich ascites tumour cells during development of resistance to daunorubicine. Acta pathologica et microbiologica Scandinavica. Section A, Pathology, 1971, Volume: 79, Issue:6 Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line; Chromosome Aberrations; Daunorubicin; Freezing; Karyotyping; Mice; Polyploidy	1971
The effect of daunomycin on human cells in vivo and in vitro. Cancer, 1969, Volume: 23, Issue:1 Topics: Aneuploidy; Bone Marrow; Bone Marrow Cells; Chromosome Aberrations; Culture Techniques; Daunorubicin; DNA, Neoplasm; Humans; Karyotyping; Leukemia, Lymphoid; Leukemia, Myeloid; Leukocytes; RNA, Neoplasm	1969
[Cytogenetic findings in chronic myeloid leukemia in childhood]. Minerva pediatrica, 1969, Mar-31, Volume: 21, Issue:13 Topics: Child; Child, Preschool; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, 21-22 and Y; Daunorubicin; Female; Humans; Leukemia, Myeloid	1969
Daunorubicin in the treatment of adult acute leukaemia. The Medical journal of Australia, 1970, Mar-28, Volume: 1, Issue:13 Topics: Acute Disease; Adolescent; Adult; Aged; Chromosome Aberrations; Daunorubicin; Female; Humans; Leukemia; Leukemia, Erythroblastic, Acute; Leukemia, Lymphoid; Leukemia, Myeloid; Leukemia, Myeloid, Acute; Male; Middle Aged; Prednisolone; Thrombocytopenia; Vincristine	1970
[Cytogenetic effects of rubidomycin (or daunomycin)]. Annales de genetique, 1968, Volume: 11, Issue:1 Topics: Bone Marrow; Bone Marrow Cells; Chromatids; Chromosome Aberrations; Culture Techniques; Daunorubicin; Humans; Lymphocytes; Polyploidy	1968
Specificity of daunomycin in causing chromosome aberrations in human leukocytes. Chromosoma, 1970, Volume: 29, Issue:1 Topics: Arginine; Cell Line; Chromatids; Chromosome Aberrations; Chromosomes, Human, 1-3; Chromosomes, Human, 13-15; Chromosomes, Human, 6-12 and X; Crossing Over, Genetic; Culture Techniques; Daunorubicin; Female; Humans; Leukocytes; Male; Receptors, Drug; Sex Chromosomes	1970
Mechanism of action of daunomycin. Acta geneticae medicae et gemellologiae, 1968, Volume: 17, Issue:1 Topics: Animals; Autoradiography; Cell Nucleolus; Cell Nucleus; Centrifugation, Density Gradient; Chromosome Aberrations; Daunorubicin; DNA; DNA Replication; HeLa Cells; Humans; In Vitro Techniques; Microscopy; Mitosis; Rats; Regeneration; Ribosomes; RNA; Thymidine; Uridine	1968
Chromosome aberrations induced by daunomycin in human leukocyte cultures, with the apparent synergistic effect of arginine. Experientia, 1968, Mar-15, Volume: 24, Issue:3 Topics: Arginine; Chromosome Aberrations; Chromosomes; Culture Techniques; Daunorubicin; Drug Synergism; Humans; Leukocytes; Mitosis; Vinblastine	1968